U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C14H19NO5
Molecular Weight 281.3044
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRIMETOZINE

SMILES

COC1=CC(=CC(OC)=C1OC)C(=O)N2CCOCC2

InChI

InChIKey=XWVOEFLBOSSYGM-UHFFFAOYSA-N
InChI=1S/C14H19NO5/c1-17-11-8-10(9-12(18-2)13(11)19-3)14(16)15-4-6-20-7-5-15/h8-9H,4-7H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C14H19NO5
Molecular Weight 281.3044
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Trimetozine (brand name Trioxazine) is a sedative agent, which has been used in the treatment of anxiety.

Originator

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
trioxazine

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
1200 mg tablet
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Record UNII
31EPT7G9PL
Record Status Validated (UNII)
Record Version